- Industry News
- Access and Reimbursement
- Law & Malpractice
- Coding & Documentation
- Practice Management
- Finance
- Technology
- Patient Engagement & Communications
- Billing & Collections
- Staffing & Salary
Administering Overseas Drugs to Medicare Patients
We are getting solicitations from companies who are selling products like Hyalgan and Boniva for less than 50 percent of the retail price in the United States. The meds are supposedly manufactured in the United States. Is purchasing medications from such companies and administering them to Medicare patients allowed?
Question: We are getting solicitations from companies who are selling products like Hyalgan and Boniva for less than 50 percent of the retail price in the United States. The meds are supposedly manufactured in the United States. Is purchasing medications from such companies and administering them to Medicare patients allowed?
Answer: There is a risk to you to selling patients drugs that the FDA has not approved (this includes all imported drugs). The Florida Board of Medicine and Florida Medical Association - as well as organizations in other states - are both against physician involvement in the importation of drugs.
Asset Protection and Financial Planning
December 6th 2021Asset protection attorney and regular Physicians Practice contributor Ike Devji and Anthony Williams, an investment advisor representative and the founder and president of Mosaic Financial Associates, discuss the impact of COVID-19 on high-earner assets and financial planning, impending tax changes, common asset protection and wealth preservation mistakes high earners make, and more.
Reducing burnout with medical scribes
November 29th 2021Physicians Practice® spoke with Fernando Mendoza, MD, FAAP, FACEP, the founder and CEO of Scrivas, LLC, about the rising rates of reported burnout among physicians and how medical scribes might be able to alleviate some pressures from physicians.
